Literature DB >> 31090382

Significance of L-carnitine in internal medicine.

Zh M Sizova1, E V Shikh1, A A Makhova1.   

Abstract

The review presents the results of a number of experimental and clinical studies proving the prospects of using L-carnitine in the clinic of internal diseases. Due to the antioxidant and antihypoxant properties, the additional use of L-carnitine in addition to the main etiopathogenetic therapy is prescribed by cardiologists, nephrologists, neurologists, gerontologists. Experimental studies we conducted earlier showed no effect of L-carnitine on the activity of the P450 CYP 3A4 system, which reduces the likelihood of drug-drug interaction at the level of metabolism of drugs metabolized by P450 3A4. When using L-carnitine as part of complex pharmacotherapy, the drug has an increased safety profile in comorbid patients taking L-carnitine. Keywords: L-carnitine, P450 CYP 3А4, chronic heart failure, myocardial infarction, chronic renal failure, inter-drug interaction, antioxidant, antihypoxant.

Entities:  

Keywords:  L-carnitine; P450 CYP 3А4; antihypoxant; antioxidant; chronic heart failure; chronic renal failure; inter-drug interaction; myocardial infarction

Mesh:

Substances:

Year:  2019        PMID: 31090382     DOI: 10.26442/00403660.2019.01.000040

Source DB:  PubMed          Journal:  Ter Arkh        ISSN: 0040-3660            Impact factor:   0.467


  3 in total

Review 1.  Mitigating the pro-oxidant state and melanogenesis of Retinitis pigmentosa: by counteracting mitochondrial dysfunction.

Authors:  Giovanni Pagano; Federico V Pallardó; Alex Lyakhovich; Luca Tiano; Marco Trifuoggi
Journal:  Cell Mol Life Sci       Date:  2021-10-31       Impact factor: 9.261

2.  The efficacy of L-carnitine in improving malnutrition in patients on maintenance hemodialysis: a meta-analysis.

Authors:  Jianwei Zhou; Tubao Yang
Journal:  Biosci Rep       Date:  2020-06-26       Impact factor: 3.840

Review 3.  Mitoprotective Clinical Strategies in Type 2 Diabetes and Fanconi Anemia Patients: Suggestions for Clinical Management of Mitochondrial Dysfunction.

Authors:  Giovanni Pagano; Federico V Pallardó; Beatriz Porto; Maria Rosa Fittipaldi; Alex Lyakhovich; Marco Trifuoggi
Journal:  Antioxidants (Basel)       Date:  2020-01-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.